Cancer is responsible for about one fourth of mortalities in the United States daily, however, early diagnosis and treatment raised the five year survival rate since the 1970's. The usage of X-ray contrast agents (XCAs) has been instrumental in the diagnosis of tumors, but the field still calls for an improved modality in XCAs, such as safe, affordable, lower dosage and targeted XCAs. Useful XCAs must be capable of avoiding the reticuloendothelial system (RES) through an increased circulation half-life time (t1/2), therefore, "evasive" nanoparticle shells have been previously constructed and studied. Researchers have demonstrated an increased t1/2 with the use of molecules such as polyethylene glycol (PEG) and silica. Evasion of RES and an increased t1/2 is primarily attributed to the decreased surface charge and robustness of said shells.
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Additionally, these properties prevent aggregation and foster further chemical modification for a targeting modality of XCAs. The following work aims to demonstrate a comprehensive synthesis and characterization of bismuth nanoparticles (BiNPs) enveloped by either silica or PEG. A qualitative approach using 1 H-NMR and FT-IR strongly suggests said coatings on BiNPs. TEM images suggest a PEG coating was formed while TEM and EDS confirms silica coatings of BiNPs.
Preliminary trials of these materials in whole mouse serum advocate silica coated BiNPs are capable of sustaining their integrity in whole serum for at least 3 hours whereas PEG coated BiNPs degrade before 12 hrs. Through an optimized synthesis of either material, conjugation of proteins on surfaces should introduce the targeting component of BiNPs. The introduction of new contrasting agents based off dense X-ray attenuating cores and higher atomic numbered (Z) elements such as Aurovist (gold nanoparticles) demonstrate both the improvement in contrast and lower dosage required through a dense X-ray opaque inorganic core, an attractive quality in site directed X-ray imaging. 4 However, the high cost of gold can present a practical challenge, discouraging the use of highly valued inorganic metal based XCAs. Thus, the need for an affordable, safe, and lower dosage contrast agent motivates the steps taken in this work.
b. The Reticuloendothelial System and Nanoparticle Core/Shell Structures
Most foreign entities that are introduced into the body are readily taken up by the reticuloendothelial system (RES) also known as the mononuclear phagocyte system (MPS).
Without an appropriate way of "cloaking" these foreign entities, sequestration by RES ( Figure 2A) is inevitable. RES functions by primarily coating said foreign entity with opsonin proteins, a molecule that triggers an immune response, facilitating sequestration of the foreign entity to the liver. This event is unfavorable if the foreign entity's (e.g. XCA) function requires a long or specific period of circulation time in the body, thus, "cloaking" molecules of foreign entities will prevent immediate RES sequestration ( Figure 2B ). Nanoparticles are attractive for specific bioapplications 5 due to their ability to avoid kidney filtration 6 and ability to avoid RES through appropriate "cloaking" chemicals. It is worth noting that it is assumed that nanoparticles with a diameter greater than 10 nm will be ideal candidates for evading sequestration by the kidneys, while nanoparticles that remain larger than 100 nm can readily be absorbed by the liver or spleen. 7, 8 Consequently, nanoparticles lend themselves for an increase in circulation half-life time (t1/2) based on factors such as, composition of the core and coatings, surface charge, size and targeting ligand functionalization. 7, 8 Through a sufficiently large t1/2, nanoparticles have demonstrated the ability to target receptors of cancer growth, 9, 10 tumor growth, 11 bone tissue damage 12 and diseased spleen. 13 Thus, it becomes evident that in order to avoid the loss of the inorganic XCA core, it must not venture alone into a physiological environment without appropriately gearing it with the capability of either avoiding RES or giving it the ability of increasing its t1/2, which in turn, will facilitate the visualization of soft tissue.
Previous work has
demonstrated an overall increase in t1/2 by covalently linking polyethylene glycol onto the surface of a contrast platform (PEGylation). PEGylation of InAs(ZnS) quantum dots, 6 gold nanocrystals, 14 and various other platforms 7 have increased t1/2 due to PEG's ability to neutralize the overall charge of the particle with a sufficiently dense coating, increased water solubility through the ethylene glycol repeats, and its ability to suppress particle aggregation and adsorption of opsonin proteins ( Figure 2B ). 7, 8, 15 For these reasons, it would be advantageous to PEGylate (covalently link) or PEG coat (a non-covalent linkage) BiNPs in efforts to conceal the central core from the body's RES. Additionally, polyethylene glycol's terminal hydroxyl moieties lends itself for even further chemical modification, this ideally can enable the construction of the wanted targeted XCA. It should be noted that a PEG coating rather than a PEGylation will not foster the ideal targeting XCA and may not even sustain small changes in solvent environments. Therefore, a way to create a PEGylated BiNP should be the synthetic goal. It is also recognized that other compounds such as silica (SiO2) constitute favorable chemical conditions for nanoparticles in physiological environments. Silica's non-cytotoxic and robust 16 nature will prevent damage to cells and "leakage" of metallic ions into solution. Silica also imparts colloidal stability in aqueous environments via a negatively charged surface, which also prevents any silica-coated particles from coming into close contact due to electrostatic repulsions. This silica surface will also accept further chemical modifications, such as amines or thiols covalently linked to a targeting moiety or biomolecule, allowing another path towards the ultimate goal of obtaining a targeted XCA. Achieving greater biocompatibility for metallic nanoparticles, namely bismuth, through the inert silica shell, 17, 18 would present a more affordable synthetic protocol of an alternative class of XCAs composed of silica coated BiNPs.
c. X-rays and Bismuth
The use of XCAs such as barium sulfate and molecular iodinated species have existed for well over half a century. By using higher atomic numbered (Z > 18) elements as XCAs, the visualization of soft tissue and other organelles composed of smaller atomic numbered elements (e.g. carbon, nitrogen, oxygen, hydrogen) can be improved, as demonstrated by current X-ray radiographs ( Figure 3 ). Therefore, by exploiting this inherent property of higher Z elements, a safer, more affordable and higher X-ray attenuating XCA can be created.
Heavy metal bismuth (Z=83), a component of the active ingredient in gastrointestinal pain
relief medication (the most common being Pepto-Bismol), possesses many advantageous qualities making it an attractive candidate as an XCA. Inherent in bismuth is its minimal cytotoxicity, 3, 19, 20 making it a surprisingly safe heavy metal given both its position and the radioactive elements that surround it on the periodic Previous bismuth nanoparticles have demonstrated the ability to target (organs and disease) and/or have high X-ray attenuation/opacity. 9 , 22, 25 Thus we venture to demonstrate a simple bench-top synthetic protocol (with two potential coatings) and suitable characterization methods.
For preliminary results of whether these nanoparticle core/shell structures will be able to sustain a physiologically similar environments, whole serum trials will be performed. It is postulated that if a PEGylated nanoparticle is constructed, the material will sustain the whole serum trial, while silica coated material should also present little issue. Preliminary studies for serum compatibilities were conducted with whole serum (MP Biomedicals, Mouse, Purified).
EXPERIMENTAL SECTION:

b. Methods
A modification to the synthetic protocol established by Brown and co-workers 3 was used to construct PEG coated BiNPs: by changing the solvent to polyethylene glycol and quartering mass and volumes of reagents, PEG coated BiNPs were synthesized and purified for characterization and further biological assays. The construction and purification of silica coated BiNPs followed much of the procedure established by Kladir et al. 26 In efforts to increase the signal to noise ratio, increased scanning trials were performed, which resulted in a subtle but enhanced signal (Figure 4: trial 1 ). This suggests stretches associated with a different chemical species, calling for a further degree of analysis since this data is insufficient to recommend that controls primarily hold BiNP/PEG. Oven dried particles became very difficult to work with, this was due to the high viscosity of the substance formed, a consequence of impurities that remained in solution, thus further complicating the analysis method and preventing a collection of a solid black material to analyze through FT-IR and 1 H-NMR. Thus, TEM and its features proved to be the best tools of analysis for these control BiNPs. vial only contained trivial unappreciable quantities of black material from large volumes of BiNP aqueous solution. Therefore, the best form of analysis was again TEM. TEM images demonstrated that completely purified BiNPs contained less impurities and debris, but a greater degree of aggregation ( Figure D) . Additionally, a change in the surface of these nanoparticles arose. This very thin shell is different from what was observed with control BiNPs shells ( Figures 7B & 7D) .
Previously, a dense core with a large thinning shell length (~10 nm) could be observed, after a full purification, particles appear to have smaller thinning shell length (~3 nm). This effect was observed in particles dialyzed at greater periods of time (> 3 hours) which additionally demonstrated precipitation in the vessel and through TEM, confirmed that there was indeed an aggregation of particles. This aggregation of BiNPs appears to initially occur after about two hours of dialysis ( Figure 7D ) strongly suggesting an issue with the final dialysis purification process.
Thus, BiNPs were then dialyzed for less than two hours in order to improve the aggregation issue, which slightly helped in resolving the problem. Therefore, shorter periods of dialysis were maintained in order to keep colloidal stability in an aqueous suspension of BiNPs. The fact that the dialysis process caused precipitation/aggregation after a short period of time may indicate the actual interacting nature of the polyethylene glycol with the BiNP core was actually more coordinating (PEG coating) rather than bonding (PEGylation). This weak interaction may give rise to complications in vivo and in vitro when the particle must sustain its integrity at different pH levels, NP concentrations and ionic strength solutions. This result advocates for an alternative route to be pursued in the preparation of PEGylated BiNPs, such as the previously demonstrated sulfur bonded gold NPs synthesis. 14
b. Silica coated BiNPs
Material in the Bi/SiO2 configuration followed the literature established Ag/SiO2 NPs synthetic protocol 26 yielding a white aqueous solution. This material was suspended in ethanol after centrifugation and was allowed to air dry for approximately 5-10 minutes, resulting in a white paste-like material that was characterized via FT-IR and TEM. This further endorses the need to optimize the synthesis for the future collection of more silica coated BiNPs. 
Summary and Conclusions:
Efforts to create a better XCA have led to the synthesis of two different kinds of BiNPs with potential increased t1/2 via molecular shells that "cloak" or are robust/inert enough to avoid RES. Control PEG coated BiNPs allude to, through TEM and EDS analysis, an organic shell composed of carbon and oxygen, strongly suggesting some type of PEG interaction with BiNPs. Upon further purification through centrifugation, a qualitative FT-IR and 1 H-NMR analysis makes the conclusion of a synthesized Bi/PEG more apparent via the varied synthetic protocol. Finally, PEG coated BiNPs post centrifugation and dialysis demonstrate particle aggregation (observed through TEM images) and precipitated material after performing extensive periods (> 3hrs) of dialysis. These types of BiNPs also revealed what appeared to be a thinning shell (~3 nm) where control particles demonstrated this shell to be greater (~10 nm). Whether these lengths are edges of elemental bismuth or shells of PEG is still inconclusive. It is also important to note that certain stages of the purification protocol were limiting to certain forms of analysis owed to issues with the collection of substantial amounts of material or material containing too much water. Preliminary whole serum trials suggest that the coating of PEG was insufficient to sustain its integrity after twelve hours of exposure to whole mouse serum, suggesting a potential t1/2 less than 12 hours for PEG coated BiNPs.
Silica coated BiNPs were also successfully synthesized through a variation of a previously established method for creating silica coated silver nanoparticles. An EDS analysis reveals a coating of a Si-O species, strongly suggesting the silica species is present. TEM images distinctly demonstrate the composition of a core/shell structure. Studies using whole serum exposure demonstrate by TEM imaging that no decomposition of Bi/SiO2 nanoparticles occured. This result is potentially indicative of a t1/2 greater than 3 hours. Future work will continue to produce similar particles with modifications in both syntheses to create more monodispersed BiNPs with their respective coatings, less debris formation, a higher payload and eventually an optimized synthesis.
Whole serum results will be used as screenings for different coatings of BiNPs. To decrease agglomeration of particles, different steps in the purification will be used in post dialysis PEG coated BiNPs, such as decreasing the time of dialysis. A different synthesis must be created to construct a PEGylated bismuth nanoparticle. Ultimately, targeting peptides of angiogenesis receptors highly expressed in tumor vasculature of lung cancer can be conjugated onto both Bi/PEG or Bi//SiO2 to target and isolate lung cancer at early stages.
Acknowledgements:
I 
